SuperGen Inc., of Dublin, Calif., was issued U.S. Patent No. 6,509,027 titled "Injectable Pharmaceutical Composition Comprising Coated Particles of Camptothecin." It covers intravenous delivery of 9-nitrocamptothecin (9-NC, Orathecin).